Good morning and welcome to another working week although this will be an abbreviated affair on this side of the pond due to the upcoming holiday The festivities however have not yet begun which means there is still much to do You know there are meetings and deadlines and all manner of busy work To start things off we are quaffing a needed cup or two stimulation and as always invite you to join us And of course here are some tidbits Hope your day goes well and do stay in touch BioMarin Pharmaceuticals agreed to pay up to  million to buy Prosensa which is developing a drug to treat a rare form of muscular dystrophy Merck and NewLink Genetics struck a licensing deal for the pharmaceutical giant to research develop make and distribution NewLinks investigational Ebola vaccine and the FDA awards or denies breakthrough designations primarily based on convincing clinical evidence of substantial efficacy an FDA official told a conference